澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

MAYNE PHARMA GROUP LTD

2.520

-0.140-5.26%

成交量：21.65万

成交额：55.31万

市值：2.06亿

市盈率：12.14

高：2.590

开：2.580

低：2.490

收：2.660

52周最高：6.500

52周最低：2.040

股本：8,189.09万

流通股本：6,699.72万

量比：2.62

换手率：0.32%

股息：- -

股息率：- -

每股收益(TTM):0.208

每股收益(LYR):0.208

净资产收益率：8.20%

总资产收益率：-1.73%

市净率：0.53

市盈率(LYR):12.14

数据加载中...

总览公司新闻资讯公告

概念

医药生物股+0.66%

资金流向

资金流入：

资金流出：

新闻资讯

Mayne Pharma集团与Italfarmaco签署澳大利亚Blissel独家五年许可协议

Mayne Pharma澄清：CEO未参与任何涉及自身激励方案的薪酬决策

异动解读 | Mayne Pharma Group盘中大涨5.58%，或因考虑股票回购计划提振市场信心

Mayne Pharma Group持续评估资本配置策略或考虑实施市场股票回购计划

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/MYX.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":2.52,"timestamp":1791781920000,"preClose":2.66,"halted":0,"volume":216511,"delay":0,"changeRate":-0.05263157894736847,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81890887,"eps":0.207588,"marketStatus":"未开盘","change":-0.14,"latestTime":"10-12 16:12:00 AEDT","open":2.58,"high":2.59,"low":2.49,"amount":553085,"amplitude":0.037594,"askPrice":2.54,"askSize":610,"bidPrice":2.51,"bidSize":3800,"shortable":3,"etf":0,"ttmEps":0.207588,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.66,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":2.62402,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MYX.AU","preClose":2.66,"auctionPrice":2.52,"auctionVolume":8396,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781803148}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.73%","roe":"8.20%","lyrEps":0.207588,"volumeRatio":2.62402,"shares":81890887,"dividePrice":0,"high":2.59,"amplitude":0.037594,"preClose":2.66,"low":2.49,"week52Low":2.04,"pbRate":"0.53","psRate":"0.54","week52High":6.5,"institutionHeld":0,"latestPrice":2.52,"committee":0.723356,"eps":0.207588,"divideRate":0,"volume":216511,"delay":0,"ttmEps":0.207588,"open":2.58,"prevYearClose":3.11,"prevWeekClose":2.66,"prevMonthClose":2.92,"prevQuarterClose":2.92,"fiveDayClose":2.82,"twentyDayClose":3.06,"sixtyDayClose":2.81,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1132428558","title":"Mayne Pharma集团与Italfarmaco签署澳大利亚Blissel独家五年许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1132428558","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132428558?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 07:52","pubTimestamp":1789429933,"startTime":"0","endTime":"0","summary":"Mayne Pharma集团宣布，已与Italfarmaco S.a签署了一项为期五年的独家许可协议。该协议针对Blissel在澳大利亚市场的推广与分销权。此举标志着Mayne Pharma在女性健康领域的战略布局进一步深化。Mayne Pharma方面表示，此次合作契合其专注于专科治疗领域的长期发展策略。通过引入Blissel这一产品，公司意在强化其在澳大利亚医疗市场中的竞争地位。而Italfarmaco则借助Mayne Pharma的本地网络，实现产品的快速渗透与市场拓展。投资者可密切关注该合作对Mayne Pharma营收结构的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174993621","title":"Mayne Pharma澄清：CEO未参与任何涉及自身激励方案的薪酬决策","url":"https://stock-news.laohu8.com/highlight/detail?id=1174993621","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174993621?lang=zh_cn&edition=fundamental","pubTime":"2026-04-30 06:25","pubTimestamp":1777501505,"startTime":"0","endTime":"0","summary":"Mayne Pharma集团今日发布声明，明确表示公司首席执行官在涉及向其本人授予激励措施的薪酬决策过程中全程回避。该制药企业强调，相关薪酬决议完全由董事会下设的薪酬委员会独立制定，确保公司治理流程符合最高标准的透明性与规范性要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161898046","title":"异动解读 | Mayne Pharma Group盘中大涨5.58%，或因考虑股票回购计划提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1161898046","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161898046?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 08:17","pubTimestamp":1777421842,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd（ASX: MYX）今日盘中大涨5.58%，引起了市场的广泛关注。消息面上，该公司表示正在持续评估最优资本配置方案，管理层考虑的策略选项中可能包含在公开市场回购公司股票的计划。市场分析人士指出，若实施股票回购计划，将有助于优化资本结构并提升股东价值，这提振了投资者信心。该公司强调，资本配置策略的审查工作仍在进行中，最终方案将综合考虑公司财务状况、市场环境及未来发展需求等因素。此次股价上涨反映了市场对公司潜在积极举措的乐观预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136228232","title":"Mayne Pharma Group持续评估资本配置策略 或考虑实施市场股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1136228232","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136228232?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 07:37","pubTimestamp":1777419437,"startTime":"0","endTime":"0","summary":"澳大利亚制药企业Mayne Pharma Group Ltd（ASX: MYX）近日表示，公司正在持续评估最优资本配置方案。据悉，管理层考虑的策略选项中可能包含在公开市场回购公司股票的计划。\n该公司强调，资本配置策略的审查工作仍在进行中，最终方案将综合考虑公司财务状况、市场环境及未来发展需求等因素。市场分析人士指出，若实施股票回购计划，将有助于优化资本结构并提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MYX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"医药生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.006583}]}}